Stroke Clinical Trials

Find Stroke Clinical Trials Near You

Synergistic Potential of Non-invasive Brain and Spinal Cord Stimulation for Improving Sensorimotor and Cognitive Functions After Neurological Injury

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure, Behavioral
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

The goal of this clinical study is to investigate the potential synergy between non-invasive brain and spinal cord stimulation administered during a cognitive-motor task, in terms of their immediate effects on sensorimotor and cognitive functions after neurological injuries affecting the upper limb (cervical spinal cord injury and stroke). Secondary objectives are to evaluate the relevance of anatomical MRI, functional MRI, and neurophysiological measurements for optimizing and predicting the effects of these different interventions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ CONTROL GROUP:

• Over 18 years of age

• Participant who has signed an informed consent form

• Participant who is affiliated with and covered by the social security system

⁃ POST-STROKE GROUP:

• Over 18 years of age

• Who sustained a stroke more than 3 weeks ago

• Considered medically stable by the medical investigator

• Who has signed an informed consent form

• Affiliated with and covered by the social security system

⁃ SCI GROUP:

• Over 18 years of age

• Considered to have a complete or incomplete spinal cord injury (i.e., with a score on the Spinal Injury Association (ASIA) Impairment Scale (AIS) score from A to D)

• Considered medically stable by the investigating physician

• Presenting with quadriplegia due to cervical injury

• Who has signed an informed consent form

• Affiliated with and covered by the social security system.

Locations
Other Locations
France
Service de Médecine Physique & Réadaptation - CHU Bordeaux
RECRUITING
Bordeaux
Centre de la Tour de Gassies
RECRUITING
Bruges
Contact Information
Primary
Nabila Brihmat, PhD
nabila.brihmat@u-bordeaux.fr
+33 5 33 51 48 46
Backup
Fabien Wagner, PhD
fabien.wagner@u-bordeaux.fr
+33 5 33 51 48 46
Time Frame
Start Date: 2024-12-11
Estimated Completion Date: 2027-12
Participants
Target number of participants: 45
Treatments
Experimental: tDCS+CMT
tDCS administered during the performance of cognitive and motor task for 20 min
Experimental: tSCS+CMT
20-min tSCS administered during the performance of cognitive and motor task for 20 min
Active_comparator: tDCS-tSCS+CMT
tDCS associated with tSCS administered during the performance of cognitive and motor task for 20 min
Sham_comparator: Sham-tDCS-tSCS+CMT
Sham tDCS associated with Sham tSCS administered during the performance of cognitive and motor task for 20 min
Related Therapeutic Areas
Sponsors
Collaborators: University Hospital, Bordeaux, Institute of Neurodegenerative Diseases, CNRS UMR 5293, Centre de la Tour de Gassies
Leads: Centre National de la Recherche Scientifique, France

This content was sourced from clinicaltrials.gov